Russian IP Status: Adequate, But Flawed For Pharma

In recent years, Russia has adopted IP reforms that bring its patent provisions closer to international standards, but enforcement remains problematic, as are dispute proceedings, in part because there’s a lack of trained judicial experts.

Russia officially joined the World Trade Organization (WTO) in August 2012, but it’s too early to gauge a direct impact from that event. Except for a reduction of the Russian Patent and Trademark Office’s (PTO) official fees for foreign companies, the WTO entry “had virtually no effect on the prosecution process,” says Oliver Henrion, a patent attorney in the German offices of Zellentin & Partners GBR. His firm services ChemRar High Tech Center, the Russian-US investment and research group, which is active in technology-transfer arrangements with foreign companies. (SeeAlso see "Priming Russia’s Pharma Industry For Innovation" - In Vivo, 17 May, 2013..)

Historically, IP legislation was rudimentary, but in recent years, Russia has adopted a series of intellectual property (IP) reforms that...

More from Archive

More from In Vivo